# Vyripharm Enterprises, L.L.C. — Form D

Vyripharm Enterprises, L.L.C. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-08. The offering totals $2.3M. Industry: Biotechnology.

## Offering

- Filed: 2016-08-08
- Form: D
- Accession: 0001079973-16-001097
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Remaining: $2.3M
- Minimum investment: $50K
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-268519

## Issuer

- Name: Vyripharm Enterprises, L.L.C.
- CIK: 0001681739
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2450 Holcombe Blvd., HOUSTON, TX, 77021
- Phone: 713-357-1045

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Jerry Bryant | Director | Houston, TX |
| Jerry Bryant | Executive Officer | Houston, TX |

## More

- [CIK 1681739 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1681739&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001079973-16-001097.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.